+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Female Contraceptive Market 2023-2027

  • PDF Icon

    Report

  • 120 Pages
  • November 2022
  • Region: Global
  • TechNavio
  • ID: 5368068
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The female contraceptive market is poised to grow by $5142.22 mn during 2023-2027, accelerating at a CAGR of 5.32% during the forecast period. The report on the female contraceptive market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the increasing adoption of innovative marketing strategies, evolving consumer perspectives, and the availability of different methods of contraception.

The female contraceptive market is segmented as below:

By Distribution Channel

  • Offline
  • Online

By Product

  • Female contraceptive devices
  • Female contraceptive drugs

By Geographical Landscape

  • North America
  • Europe
  • APAC
  • South America
  • Middle East and Africa
This study identifies the increasing popularity of female condoms as one of the prime reasons driving the female contraceptive market growth during the next few years. Also, technological advances in IUSs and the high growth of e-commerce platforms will lead to sizable demand in the market.

The report on the female contraceptive market covers the following areas:

  • Female contraceptive market sizing
  • Female contraceptive market forecast
  • Female contraceptive market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading female contraceptive market vendors that include AbbVie Inc., Afaxys Pharma LLC, Agile Therapeutics Inc., Amgen Inc., Ansell Ltd., Bayer AG, CooperSurgical Inc., Cupid Ltd., Exeltis USA Inc., Johnson and Johnson, Mayer Laboratories Inc., Medisafe Distribution Inc., Merck and Co. Inc., Mylan NV, Pfizer Inc., Piramal Enterprises Ltd., Reckitt Benckiser Group PLC, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., and Veru Inc. Also, the female contraceptive market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibit 06: Executive Summary - Chart on Market Segmentation by Product
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
2 Market Landscape
2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics
3 Market Sizing
3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2022
3.4 Market outlook: Forecast for 2022-2027
Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
4 Historic Market Size
4.1 Global female contraceptive market 2017 - 2021
Exhibit 18: Historic Market Size - Data Table on Global female contraceptive market 2017 - 2021 ($ million)
4.2 Distribution Channel Segment Analysis 2017 - 2021
Exhibit 19: Historic Market Size - Distribution Channel Segment 2017 - 2021 ($ million)
4.3 Product Segment Analysis 2017 - 2021
Exhibit 20: Historic Market Size - Product Segment 2017 - 2021 ($ million)
4.4 Geography Segment Analysis 2017 - 2021
Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
4.5 Country Segment Analysis 2017 - 2021
Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
5 Five Forces Analysis
5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2022 and 2027
6 Market Segmentation by Distribution Channel
6.1 Market segments
Exhibit 30: Chart on Distribution Channel - Market share 2022-2027 (%)
Exhibit 31: Data Table on Distribution Channel - Market share 2022-2027 (%)
6.2 Comparison by Distribution Channel
Exhibit 32: Chart on Comparison by Distribution Channel
Exhibit 33: Data Table on Comparison by Distribution Channel
6.3 Offline - Market size and forecast 2022-2027
Exhibit 34: Chart on Offline - Market size and forecast 2022-2027 ($ million)
Exhibit 35: Data Table on Offline - Market size and forecast 2022-2027 ($ million)
Exhibit 36: Chart on Offline - Year-over-year growth 2022-2027 (%)
Exhibit 37: Data Table on Offline - Year-over-year growth 2022-2027 (%)
6.4 Online - Market size and forecast 2022-2027
Exhibit 38: Chart on Online - Market size and forecast 2022-2027 ($ million)
Exhibit 39: Data Table on Online - Market size and forecast 2022-2027 ($ million)
Exhibit 40: Chart on Online - Year-over-year growth 2022-2027 (%)
Exhibit 41: Data Table on Online - Year-over-year growth 2022-2027 (%)
6.5 Market opportunity by Distribution Channel
Exhibit 42: Market opportunity by Distribution Channel ($ million)
7 Market Segmentation by Product
7.1 Market segments
Exhibit 43: Chart on Product - Market share 2022-2027 (%)
Exhibit 44: Data Table on Product - Market share 2022-2027 (%)
7.2 Comparison by Product
Exhibit 45: Chart on Comparison by Product
Exhibit 46: Data Table on Comparison by Product
7.3 Female contraceptive devices - Market size and forecast 2022-2027
Exhibit 47: Chart on Female contraceptive devices - Market size and forecast 2022-2027 ($ million)
Exhibit 48: Data Table on Female contraceptive devices - Market size and forecast 2022-2027 ($ million)
Exhibit 49: Chart on Female contraceptive devices - Year-over-year growth 2022-2027 (%)
Exhibit 50: Data Table on Female contraceptive devices - Year-over-year growth 2022-2027 (%)
7.4 Female contraceptive drugs - Market size and forecast 2022-2027
Exhibit 51: Chart on Female contraceptive drugs - Market size and forecast 2022-2027 ($ million)
Exhibit 52: Data Table on Female contraceptive drugs - Market size and forecast 2022-2027 ($ million)
Exhibit 53: Chart on Female contraceptive drugs - Year-over-year growth 2022-2027 (%)
Exhibit 54: Data Table on Female contraceptive drugs - Year-over-year growth 2022-2027 (%)
7.5 Market opportunity by Product
Exhibit 55: Market opportunity by Product ($ million)
8 Customer Landscape
8.1 Customer landscape overview
Exhibit 56: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape
9.1 Geographic segmentation
Exhibit 57: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibit 58: Data Table on Market share By Geographical Landscape 2022-2027 (%)
9.2 Geographic comparison
Exhibit 59: Chart on Geographic comparison
Exhibit 60: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2022-2027
Exhibit 61: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 62: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 63: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibit 64: Data Table on North America - Year-over-year growth 2022-2027 (%)
9.4 Europe - Market size and forecast 2022-2027
Exhibit 65: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 66: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 67: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibit 68: Data Table on Europe - Year-over-year growth 2022-2027 (%)
9.5 APAC - Market size and forecast 2022-2027
Exhibit 69: Chart on APAC - Market size and forecast 2022-2027 ($ million)
Exhibit 70: Data Table on APAC - Market size and forecast 2022-2027 ($ million)
Exhibit 71: Chart on APAC - Year-over-year growth 2022-2027 (%)
Exhibit 72: Data Table on APAC - Year-over-year growth 2022-2027 (%)
9.6 South America - Market size and forecast 2022-2027
Exhibit 73: Chart on South America - Market size and forecast 2022-2027 ($ million)
Exhibit 74: Data Table on South America - Market size and forecast 2022-2027 ($ million)
Exhibit 75: Chart on South America - Year-over-year growth 2022-2027 (%)
Exhibit 76: Data Table on South America - Year-over-year growth 2022-2027 (%)
9.7 Middle East and Africa - Market size and forecast 2022-2027
Exhibit 77: Chart on Middle East and Africa - Market size and forecast 2022-2027 ($ million)
Exhibit 78: Data Table on Middle East and Africa - Market size and forecast 2022-2027 ($ million)
Exhibit 79: Chart on Middle East and Africa - Year-over-year growth 2022-2027 (%)
Exhibit 80: Data Table on Middle East and Africa - Year-over-year growth 2022-2027 (%)
9.8 US - Market size and forecast 2022-2027
Exhibit 81: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibit 82: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibit 83: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibit 84: Data Table on US - Year-over-year growth 2022-2027 (%)
9.9 China - Market size and forecast 2022-2027
Exhibit 85: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibit 86: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibit 87: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibit 88: Data Table on China - Year-over-year growth 2022-2027 (%)
9.10 France - Market size and forecast 2022-2027
Exhibit 89: Chart on France - Market size and forecast 2022-2027 ($ million)
Exhibit 90: Data Table on France - Market size and forecast 2022-2027 ($ million)
Exhibit 91: Chart on France - Year-over-year growth 2022-2027 (%)
Exhibit 92: Data Table on France - Year-over-year growth 2022-2027 (%)
9.11 Canada - Market size and forecast 2022-2027
Exhibit 93: Chart on Canada - Market size and forecast 2022-2027 ($ million)
Exhibit 94: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
Exhibit 95: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibit 96: Data Table on Canada - Year-over-year growth 2022-2027 (%)
9.12 Japan - Market size and forecast 2022-2027
Exhibit 97: Chart on Japan - Market size and forecast 2022-2027 ($ million)
Exhibit 98: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
Exhibit 99: Chart on Japan - Year-over-year growth 2022-2027 (%)
Exhibit 100: Data Table on Japan - Year-over-year growth 2022-2027 (%)
9.13 Market opportunity By Geographical Landscape
Exhibit 101: Market opportunity By Geographical Landscape ($ million)
10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 102: Impact of drivers and challenges in 2022 and 2027
10.4 Market trends
11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
Exhibit 103: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 104: Overview on factors of disruption
11.4 Industry risks
Exhibit 105: Impact of key risks on business
12 Vendor Analysis
12.1 Vendors covered
Exhibit 106: Vendors covered
12.2 Market positioning of vendors
Exhibit 107: Matrix on vendor position and classification
12.3 AbbVie Inc.
Exhibit 108: AbbVie Inc. - Overview
Exhibit 109: AbbVie Inc. - Product/Service
Exhibit 110: AbbVie Inc. - Key offerings
12.4 Afaxys Pharma LLC
Exhibit 111: Afaxys Pharma LLC - Overview
Exhibit 112: Afaxys Pharma LLC - Product/Service
Exhibit 113: Afaxys Pharma LLC - Key offerings
12.5 Agile Therapeutics Inc.
Exhibit 114: Agile Therapeutics Inc. - Overview
Exhibit 115: Agile Therapeutics Inc. - Product/Service
Exhibit 116: Agile Therapeutics Inc. - Key offerings
12.6 Ansell Ltd.
Exhibit 117: Ansell Ltd. - Overview
Exhibit 118: Ansell Ltd. - Business segments
Exhibit 119: Ansell Ltd. - Key news
Exhibit 120: Ansell Ltd. - Key offerings
Exhibit 121: Ansell Ltd. - Segment focus
12.7 Bayer AG
Exhibit 122: Bayer AG - Overview
Exhibit 123: Bayer AG - Business segments
Exhibit 124: Bayer AG - Key offerings
Exhibit 125: Bayer AG - Segment focus
12.8 CooperSurgical Inc.
Exhibit 126: CooperSurgical Inc. - Overview
Exhibit 127: CooperSurgical Inc. - Product/Service
Exhibit 128: CooperSurgical Inc. - Key offerings
12.9 Cupid Ltd.
Exhibit 129: Cupid Ltd. - Overview
Exhibit 130: Cupid Ltd. - Product/Service
Exhibit 131: Cupid Ltd. - Key offerings
12.10 Johnson and Johnson
Exhibit 132: Johnson and Johnson - Overview
Exhibit 133: Johnson and Johnson - Business segments
Exhibit 134: Johnson and Johnson - Key news
Exhibit 135: Johnson and Johnson - Key offerings
Exhibit 136: Johnson and Johnson - Segment focus
12.11 Mayer Laboratories Inc.
Exhibit 137: Mayer Laboratories Inc. - Overview
Exhibit 138: Mayer Laboratories Inc. - Product/Service
Exhibit 139: Mayer Laboratories Inc. - Key offerings
12.12 Merck and Co. Inc.
Exhibit 140: Merck and Co. Inc. - Overview
Exhibit 141: Merck and Co. Inc. - Business segments
Exhibit 142: Merck and Co. Inc. - Key news
Exhibit 143: Merck and Co. Inc. - Key offerings
Exhibit 144: Merck and Co. Inc. - Segment focus
12.13 Mylan NV
Exhibit 145: Mylan NV - Overview
Exhibit 146: Mylan NV - Business segments
Exhibit 147: Mylan NV - Key offerings
Exhibit 148: Mylan NV - Segment focus
12.14 Pfizer Inc.
Exhibit 149: Pfizer Inc. - Overview
Exhibit 150: Pfizer Inc. - Product/Service
Exhibit 151: Pfizer Inc. - Key news
Exhibit 152: Pfizer Inc. - Key offerings
12.15 Reckitt Benckiser Group PLC
Exhibit 153: Reckitt Benckiser Group PLC - Overview
Exhibit 154: Reckitt Benckiser Group PLC - Business segments
Exhibit 155: Reckitt Benckiser Group PLC - Key offerings
Exhibit 156: Reckitt Benckiser Group PLC - Segment focus
12.16 Teva Pharmaceutical Industries Ltd.
Exhibit 157: Teva Pharmaceutical Industries Ltd. - Overview
Exhibit 158: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibit 159: Teva Pharmaceutical Industries Ltd. - Key news
Exhibit 160: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibit 161: Teva Pharmaceutical Industries Ltd. - Segment focus
12.17 Veru Inc.
Exhibit 162: Veru Inc. - Overview
Exhibit 163: Veru Inc. - Business segments
Exhibit 164: Veru Inc. - Key offerings
Exhibit 165: Veru Inc. - Segment focus
13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 166: Inclusions checklist
Exhibit 167: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 168: Currency conversion rates for US$
13.4 Research methodology
Exhibit 169: Research methodology
Exhibit 170: Validation techniques employed for market sizing
Exhibit 171: Information sources
13.5 List of abbreviations
Exhibit 172: List of abbreviations
List of Exhibits
Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits 5: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibits 6: Executive Summary - Chart on Market Segmentation by Product
Exhibits 7: Executive Summary - Chart on Incremental Growth
Exhibits 8: Executive Summary - Data Table on Incremental Growth
Exhibits 9: Executive Summary - Chart on Vendor Market Positioning
Exhibits 10: Parent market
Exhibits 11: Market Characteristics
Exhibits 12: Offerings of vendors included in the market definition
Exhibits 13: Market segments
Exhibits 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibits 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibits 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits 18: Historic Market Size - Data Table on Global female contraceptive market 2017 - 2021 ($ million)
Exhibits 19: Historic Market Size - Distribution Channel Segment 2017 - 2021 ($ million)
Exhibits 20: Historic Market Size - Product Segment 2017 - 2021 ($ million)
Exhibits 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
Exhibits 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
Exhibits 23: Five forces analysis - Comparison between 2022 and 2027
Exhibits 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits 26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits 27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits 28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits 29: Chart on Market condition - Five forces 2022 and 2027
Exhibits 30: Chart on Distribution Channel - Market share 2022-2027 (%)
Exhibits 31: Data Table on Distribution Channel - Market share 2022-2027 (%)
Exhibits 32: Chart on Comparison by Distribution Channel
Exhibits 33: Data Table on Comparison by Distribution Channel
Exhibits 34: Chart on Offline - Market size and forecast 2022-2027 ($ million)
Exhibits 35: Data Table on Offline - Market size and forecast 2022-2027 ($ million)
Exhibits 36: Chart on Offline - Year-over-year growth 2022-2027 (%)
Exhibits 37: Data Table on Offline - Year-over-year growth 2022-2027 (%)
Exhibits 38: Chart on Online - Market size and forecast 2022-2027 ($ million)
Exhibits 39: Data Table on Online - Market size and forecast 2022-2027 ($ million)
Exhibits 40: Chart on Online - Year-over-year growth 2022-2027 (%)
Exhibits 41: Data Table on Online - Year-over-year growth 2022-2027 (%)
Exhibits 42: Market opportunity by Distribution Channel ($ million)
Exhibits 43: Chart on Product - Market share 2022-2027 (%)
Exhibits 44: Data Table on Product - Market share 2022-2027 (%)
Exhibits 45: Chart on Comparison by Product
Exhibits 46: Data Table on Comparison by Product
Exhibits 47: Chart on Female contraceptive devices - Market size and forecast 2022-2027 ($ million)
Exhibits 48: Data Table on Female contraceptive devices - Market size and forecast 2022-2027 ($ million)
Exhibits 49: Chart on Female contraceptive devices - Year-over-year growth 2022-2027 (%)
Exhibits 50: Data Table on Female contraceptive devices - Year-over-year growth 2022-2027 (%)
Exhibits 51: Chart on Female contraceptive drugs - Market size and forecast 2022-2027 ($ million)
Exhibits 52: Data Table on Female contraceptive drugs - Market size and forecast 2022-2027 ($ million)
Exhibits 53: Chart on Female contraceptive drugs - Year-over-year growth 2022-2027 (%)
Exhibits 54: Data Table on Female contraceptive drugs - Year-over-year growth 2022-2027 (%)
Exhibits 55: Market opportunity by Product ($ million)
Exhibits 56: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 57: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits 58: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits 59: Chart on Geographic comparison
Exhibits 60: Data Table on Geographic comparison
Exhibits 61: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibits 62: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibits 63: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits 64: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits 65: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits 66: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits 67: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits 68: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits 69: Chart on APAC - Market size and forecast 2022-2027 ($ million)
Exhibits 70: Data Table on APAC - Market size and forecast 2022-2027 ($ million)
Exhibits 71: Chart on APAC - Year-over-year growth 2022-2027 (%)
Exhibits 72: Data Table on APAC - Year-over-year growth 2022-2027 (%)
Exhibits 73: Chart on South America - Market size and forecast 2022-2027 ($ million)
Exhibits 74: Data Table on South America - Market size and forecast 2022-2027 ($ million)
Exhibits 75: Chart on South America - Year-over-year growth 2022-2027 (%)
Exhibits 76: Data Table on South America - Year-over-year growth 2022-2027 (%)
Exhibits 77: Chart on Middle East and Africa - Market size and forecast 2022-2027 ($ million)
Exhibits 78: Data Table on Middle East and Africa - Market size and forecast 2022-2027 ($ million)
Exhibits 79: Chart on Middle East and Africa - Year-over-year growth 2022-2027 (%)
Exhibits 80: Data Table on Middle East and Africa - Year-over-year growth 2022-2027 (%)
Exhibits 81: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibits 82: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibits 83: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits 84: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits 85: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibits 86: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibits 87: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibits 88: Data Table on China - Year-over-year growth 2022-2027 (%)
Exhibits 89: Chart on France - Market size and forecast 2022-2027 ($ million)
Exhibits 90: Data Table on France - Market size and forecast 2022-2027 ($ million)
Exhibits 91: Chart on France - Year-over-year growth 2022-2027 (%)
Exhibits 92: Data Table on France - Year-over-year growth 2022-2027 (%)
Exhibits 93: Chart on Canada - Market size and forecast 2022-2027 ($ million)
Exhibits 94: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
Exhibits 95: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibits 96: Data Table on Canada - Year-over-year growth 2022-2027 (%)
Exhibits 97: Chart on Japan - Market size and forecast 2022-2027 ($ million)
Exhibits 98: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
Exhibits 99: Chart on Japan - Year-over-year growth 2022-2027 (%)
Exhibits 100: Data Table on Japan - Year-over-year growth 2022-2027 (%)
Exhibits 101: Market opportunity By Geographical Landscape ($ million)
Exhibits 102: Impact of drivers and challenges in 2022 and 2027
Exhibits 103: Overview on Criticality of inputs and Factors of differentiation
Exhibits 104: Overview on factors of disruption
Exhibits 105: Impact of key risks on business
Exhibits 106: Vendors covered
Exhibits 107: Matrix on vendor position and classification
Exhibits 108: AbbVie Inc. - Overview
Exhibits 109: AbbVie Inc. - Product/Service
Exhibits 110: AbbVie Inc. - Key offerings
Exhibits 111: Afaxys Pharma LLC - Overview
Exhibits 112: Afaxys Pharma LLC - Product/Service
Exhibits 113: Afaxys Pharma LLC - Key offerings
Exhibits 114: Agile Therapeutics Inc. - Overview
Exhibits 115: Agile Therapeutics Inc. - Product/Service
Exhibits 116: Agile Therapeutics Inc. - Key offerings
Exhibits 117: Ansell Ltd. - Overview
Exhibits 118: Ansell Ltd. - Business segments
Exhibits 119: Ansell Ltd. - Key news
Exhibits 120: Ansell Ltd. - Key offerings
Exhibits 121: Ansell Ltd. - Segment focus
Exhibits 122: Bayer AG - Overview
Exhibits 123: Bayer AG - Business segments
Exhibits 124: Bayer AG - Key offerings
Exhibits 125: Bayer AG - Segment focus
Exhibits 126: CooperSurgical Inc. - Overview
Exhibits 127: CooperSurgical Inc. - Product/Service
Exhibits 128: CooperSurgical Inc. - Key offerings
Exhibits 129: Cupid Ltd. - Overview
Exhibits 130: Cupid Ltd. - Product/Service
Exhibits 131: Cupid Ltd. - Key offerings
Exhibits 132: Johnson and Johnson - Overview
Exhibits 133: Johnson and Johnson - Business segments
Exhibits 134: Johnson and Johnson - Key news
Exhibits 135: Johnson and Johnson - Key offerings
Exhibits 136: Johnson and Johnson - Segment focus
Exhibits 137: Mayer Laboratories Inc. - Overview
Exhibits 138: Mayer Laboratories Inc. - Product/Service
Exhibits 139: Mayer Laboratories Inc. - Key offerings
Exhibits 140: Merck and Co. Inc. - Overview
Exhibits 141: Merck and Co. Inc. - Business segments
Exhibits 142: Merck and Co. Inc. - Key news
Exhibits 143: Merck and Co. Inc. - Key offerings
Exhibits 144: Merck and Co. Inc. - Segment focus
Exhibits 145: Mylan NV - Overview
Exhibits 146: Mylan NV - Business segments
Exhibits 147: Mylan NV - Key offerings
Exhibits 148: Mylan NV - Segment focus
Exhibits 149: Pfizer Inc. - Overview
Exhibits 150: Pfizer Inc. - Product/Service
Exhibits 151: Pfizer Inc. - Key news
Exhibits 152: Pfizer Inc. - Key offerings
Exhibits 153: Reckitt Benckiser Group PLC - Overview
Exhibits 154: Reckitt Benckiser Group PLC - Business segments
Exhibits 155: Reckitt Benckiser Group PLC - Key offerings
Exhibits 156: Reckitt Benckiser Group PLC - Segment focus
Exhibits 157: Teva Pharmaceutical Industries Ltd. - Overview
Exhibits 158: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibits 159: Teva Pharmaceutical Industries Ltd. - Key news
Exhibits 160: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibits 161: Teva Pharmaceutical Industries Ltd. - Segment focus
Exhibits 162: Veru Inc. - Overview
Exhibits 163: Veru Inc. - Business segments
Exhibits 164: Veru Inc. - Key offerings
Exhibits 165: Veru Inc. - Segment focus
Exhibits 166: Inclusions checklist
Exhibits 167: Exclusions checklist
Exhibits 168: Currency conversion rates for US$
Exhibits 169: Research methodology
Exhibits 170: Validation techniques employed for market sizing
Exhibits 171: Information sources
Exhibits 172: List of abbreviations

Executive Summary

The publisher recognizes the following companies as the key players in the global female contraceptive market: AbbVie Inc., Afaxys Pharma LLC, Agile Therapeutics Inc., Amgen Inc., Ansell Ltd., Bayer AG, CooperSurgical Inc., Cupid Ltd., Exeltis USA Inc., Johnson and Johnson, Mayer Laboratories Inc., Medisafe Distribution Inc., Merck and Co. Inc., Mylan NV, Pfizer Inc., Piramal Enterprises Ltd., Reckitt Benckiser Group PLC, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., and Veru Inc.

Commenting on the report, an analyst from the research team said: `The latest trend gaining momentum in the market is increasing popularity of female condoms.`

According to the report, one of the major drivers for this market is the increasing adoption of innovative marketing strategies.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • AbbVie Inc.
  • Afaxys Pharma LLC
  • Agile Therapeutics Inc.
  • Amgen Inc.
  • Ansell Ltd.
  • Bayer AG
  • CooperSurgical Inc.
  • Cupid Ltd.
  • Exeltis USA Inc.
  • Johnson and Johnson
  • Mayer Laboratories Inc.
  • Medisafe Distribution Inc.
  • Merck and Co. Inc.
  • Mylan NV
  • Pfizer Inc.
  • Piramal Enterprises Ltd.
  • Reckitt Benckiser Group PLC
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Veru Inc.

Related Topics

Related Reports

World - Condoms (Sheath Contraceptives) - Market Analysis, Forecast, Size, Trends and Insights - Product Image

World - Condoms (Sheath Contraceptives) - Market Analysis, Forecast, Size, Trends and Insights

  • Report
  • Global
From
Global Female Contraceptive Market by Contraceptive Drug (Contraceptive Injections, Contraceptive Pills, Spermicides), Contraceptive Devices (Contraceptive Patches, Contraceptive Sponges, Diaphragms & Caps), Distribution Channel - Forecast 2024-2030 - Product Image

Global Female Contraceptive Market by Contraceptive Drug (Contraceptive Injections, Contraceptive Pills, Spermicides), Contraceptive Devices (Contraceptive Patches, Contraceptive Sponges, Diaphragms & Caps), Distribution Channel - Forecast 2024-2030

  • Report
  • 183 Pages
  • Global
From
Global Contraceptive Market Analysis & Forecast to 2023-2033: Market By Product; By Gender; By Distribution Channel; and By Region - Product Image

Global Contraceptive Market Analysis & Forecast to 2023-2033: Market By Product; By Gender; By Distribution Channel; and By Region

  • Report
  • 145 Pages
  • Global
From
Female Contraceptives in Major Markets, Disease Management, Epidemiology, Pipeline Assessment, Unmet Needs and Drug Forecast to 2032 - Product Image

Female Contraceptives in Major Markets, Disease Management, Epidemiology, Pipeline Assessment, Unmet Needs and Drug Forecast to 2032

  • Report
  • 61 Pages
  • Global
From
Contraceptive Devices Market- Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented By Product Type, By Distribution Channel, By End User, By Region - Product Image

Contraceptive Devices Market- Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented By Product Type, By Distribution Channel, By End User, By Region

  • Report
  • 112 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.